Atlas Trials

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Clinical trial NCT03905655 · COMPLETED

Trial details

NCT number
NCT03905655
Sponsor
Romark Laboratories L.C.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2019-10-22
Primary completion
2021-03-10
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.